Author:
Jakhetia Richa,Marri Aruna,Ståhle Jonas,Widmalm Göran,Verma Naresh K
Publisher
Springer Science and Business Media LLC
Reference42 articles.
1. Kotloff KL, Winickoff JP, Ivanoff B, Clemens JD, Swerdlow DL, Sansonetti PJ, Adak GK, Levine MM: Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999, 77 (8): 651-666.
2. Morona R, Daniels C, Van Den Bosch L: Genetic modulation of Shigella flexneri 2a lipopolysaccharide O antigen modal chain length reveals that it has been optimized for virulence. Microbiology. 2003, 149 (Pt 4): 925-939.
3. Allison GE, Verma NK: Serotype-converting bacteriophages and O-antigen modification in Shigella flexneri. Trends Microbiol. 2000, 8 (1): 17-23. 10.1016/S0966-842X(99)01646-7.
4. Foster RA, Carlin NI, Majcher M, Tabor H, Ng LK, Widmalm G: Structural elucidation of the O-antigen of the Shigella flexneri provisional serotype 88-893: structural and serological similarities with S. flexneri provisional serotype Y394 (1c). Carbohydr Res. 2011, 346 (6): 872-876. 10.1016/j.carres.2011.02.013.
5. Kenne L, Lindberg B, Petersson K: Basic structure of the oligosaccharide repeating-unit of the Shigellaflexneri O-antigens. Carbohydr Res. 1977, 56 (2): 363-370. 10.1016/S0008-6215(00)83357-1.